arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

ORASURE TECHNOLOGIES INC

OSUR
$4.05 ▲ +0.05 (+1.25%) at close
Healthcare ·Surgical & Medical Instruments & Apparatus ·USSurgical & Medical Instruments & Apparatus
18 Visible periods
29 Metrics
Peer-ranked Benchmarks
Price Chart
22
Health
Poor
Bearish
auto_awesome

Analytical Summary

ORASURE TECHNOLOGIES INC faces fundamental challenges with weakness in Profit Margin (%) and Operating Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $297.6M
Dividend Yield
Revenue Growth -38.1%
Op. Margin -62.6%
ROIC -21.7%
FCF / Share $-0.72
Trailing P/E
Price / Book 0.8x
FCF Yield
Debt / Equity
info Valuation on last close. End-of-day price, Aug 7, 2026.

18-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$115.02M
↓ -38.1%
Net Income Profit after all expenses
$-68.73M
↓ -252.5%
Operating Margin Operating profit as % of sales
-62.6%
↓ -311.6% 4th
FCF / Share Free cash flow per share
$-0.72
↓ -328.6%
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile

Health Breakdown

Profitability
5
Returns
28
Cash Quality
52

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 18 years · 67 quarters